Aegon is down 1% and thus underperforming the trend in Amsterdam, under the weight of a recommendation downgrade by UBS from 'buy' to 'neutral' on the insurance company's stock, despite a price target raised from 6.3 to 6.65 euros.

The broker believes that the risk/reward ratio is now balanced, between risks such as exposure to US commercial real estate, and upside potential such as higher returns on capital.

Copyright (c) 2024 CercleFinance.com. All rights reserved.